Home
KNSA
KNSA News

Latest Kiniksa Pharmaceuticals Ltd. (KNSA) News on December 23, 2024

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

2 days ago

Exploring Three High Growth Tech Stocks In The United States

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire

a month ago

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

MT Newswires

a month ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $357,680, According to a Recent SEC Filing

Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025?

Insider Monkey

a month ago

Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025?

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

GlobeNewswire

a month ago

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Simply Wall St.

2 months ago

Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

2 months ago

Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Kiniksa Pharmaceuticals Ltd Earnings Call

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ...

GuruFocus.com

2 months ago

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ...

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue Estimates

Zacks

2 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue Estimates

MT Newswires

2 months ago

Kiniksa Pharmaceuticals Q3 Loss Narrows, Revenue Rises

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

GlobeNewswire

2 months ago

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

What To Expect From Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings

GuruFocus.com

2 months ago

What To Expect From Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

GlobeNewswire

2 months ago

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

GlobeNewswire

2 months ago

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In October 2024

Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet

Zacks

2 months ago

Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet

Baker Bros. Advisors LP Increases Stake in Kiniksa Pharmaceuticals

GuruFocus.com

2 months ago

Baker Bros. Advisors LP Increases Stake in Kiniksa Pharmaceuticals

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

GlobeNewswire

3 months ago

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

MT Newswires

3 months ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $437,325, According to a Recent SEC Filing

Top High Growth Tech Stocks To Watch In September 2024

Simply Wall St.

3 months ago

Top High Growth Tech Stocks To Watch In September 2024

MT Newswires

3 months ago

Jefferies Initiates Kiniksa Pharmaceuticals at Buy With $40 Price Target

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

GlobeNewswire

4 months ago

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

Wall Street Analysts Believe Kiniksa Pharmaceuticals (KNSA) Could Rally 30.11%: Here's is How to Trade

Zacks

5 months ago

Wall Street Analysts Believe Kiniksa Pharmaceuticals (KNSA) Could Rally 30.11%: Here's is How to Trade

Zacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp

Zacks

5 months ago

Zacks.com featured highlights include Kiniksa Pharmaceuticals, HNI, AudioEye, Balchem and The Gorman-Rupp

5 Stocks With Recent Price Strength in a Volatile Market

Zacks

5 months ago

5 Stocks With Recent Price Strength in a Volatile Market

Kiniksa Pharmaceuticals, Ltd. (KNSA) Is Up 0.09% in One Week: What You Should Know

Zacks

5 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Is Up 0.09% in One Week: What You Should Know

MT Newswires

5 months ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $3,491,947, According to a Recent SEC Filing

Recent Price Trend in Kiniksa Pharmaceuticals (KNSA) is Your Friend, Here's Why

Zacks

5 months ago

Recent Price Trend in Kiniksa Pharmaceuticals (KNSA) is Your Friend, Here's Why

MT Newswires

5 months ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $601,108, According to a Recent SEC Filing

MT Newswires

5 months ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $578,966, According to a Recent SEC Filing

Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates

Simply Wall St.

5 months ago

Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates

MT Newswires

5 months ago

Wedbush Adjusts Price Target on Kiniksa Pharmaceuticals to $34 From $30, Maintains Outperform Rating

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q2 Loss, Tops Revenue Estimates

Zacks

5 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q2 Loss, Tops Revenue Estimates

MT Newswires

5 months ago

Kiniksa Pharmaceuticals Swings to Q2 Loss, Revenue Increases

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

GlobeNewswire

5 months ago

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

GlobeNewswire

5 months ago

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

The 13% return this week takes Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) shareholders three-year gains to 60%

Simply Wall St.

5 months ago

The 13% return this week takes Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) shareholders three-year gains to 60%

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

GlobeNewswire

5 months ago

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease

MT Newswires

6 months ago

Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf

MT Newswires

6 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

MT Newswires

6 months ago

Kiniksa Pharmaceuticals Signs Deal With Samsung Biologics for Arcalyst Supply

MT Newswires

6 months ago

Kiniksa Collaborates With NHL Hall-of-Famer Henrik Lundqvist on Pericarditis Awareness Campaign

Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis

GlobeNewswire

6 months ago

Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative

GlobeNewswire

6 months ago

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

6 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

6 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

6 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

6 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

6 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

6 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

6 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

6 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

6 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

6 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

6 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

6 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

6 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

6 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

6 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

6 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

7 months ago

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

GlobeNewswire

8 months ago

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report

Simply Wall St.

8 months ago

Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After Its First-Quarter Report

Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

8 months ago

Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript

Insider Monkey

8 months ago

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript

GuruFocus.com

8 months ago

Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

Zacks

8 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

MT Newswires

8 months ago

Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

GlobeNewswire

8 months ago

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

GlobeNewswire

8 months ago

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

GlobeNewswire

9 months ago

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why

Zacks

10 months ago

Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why

Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts Expect?

Zacks

10 months ago

Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts Expect?

Kiniksa Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

10 months ago

Kiniksa Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Chief Medical Officer John Paolini Sells 10,156 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)

GuruFocus.com

10 months ago

Chief Medical Officer John Paolini Sells 10,156 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)

Are You Looking for a Top Momentum Pick? Why Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Great Choice

Zacks

10 months ago

Are You Looking for a Top Momentum Pick? Why Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Great Choice

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

10 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable

Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass Estimates

Zacks

10 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass Estimates

GuruFocus.com

10 months ago

Kiniksa Pharmaceuticals Ltd (KNSA) Reports Strong Revenue Growth in Q4 and Full-Year 2023

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

GlobeNewswire

10 months ago

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

GlobeNewswire

10 months ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Wall Street Analysts Predict a 38.07% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Here's What You Should Know

Zacks

10 months ago

Wall Street Analysts Predict a 38.07% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Here's What You Should Know

Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

10 months ago

Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable

President & CEO Brian Lian Sells 85,000 Shares of Viking Therapeutics Inc

GuruFocus.com

a year ago

President & CEO Brian Lian Sells 85,000 Shares of Viking Therapeutics Inc

Murphy USA (MUSA) Q4 Earnings Preview: What You Need to Know

Zacks

a year ago

Murphy USA (MUSA) Q4 Earnings Preview: What You Need to Know

Barnes Group Inc. (NYSE:B) Shares Could Be 23% Below Their Intrinsic Value Estimate

Simply Wall St.

a year ago

Barnes Group Inc. (NYSE:B) Shares Could Be 23% Below Their Intrinsic Value Estimate

Q3 Earnings Highs And Lows: McDonald's (NYSE:MCD) Vs The Rest Of The Traditional Fast Food Stocks

StockStory

a year ago

Q3 Earnings Highs And Lows: McDonald's (NYSE:MCD) Vs The Rest Of The Traditional Fast Food Stocks

Where Will Palantir Stock Be in 2025?

Motley Fool

a year ago

Where Will Palantir Stock Be in 2025?

NextEra Energy, Inc. (NYSE:NEE) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

NextEra Energy, Inc. (NYSE:NEE) Q4 2023 Earnings Call Transcript

Weyerhaeuser (WY) Surpasses Q4 Earnings Estimates

Zacks

a year ago

Weyerhaeuser (WY) Surpasses Q4 Earnings Estimates

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX

Zacks

a year ago

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX

How Much Upside is Left in Kiniksa Pharmaceuticals, Ltd. (KNSA)? Wall Street Analysts Think 43.93%

Zacks

a year ago

How Much Upside is Left in Kiniksa Pharmaceuticals, Ltd. (KNSA)? Wall Street Analysts Think 43.93%

5 Soft Drink Stocks to Watch Amid Favorable Industry Trends

Zacks

a year ago

5 Soft Drink Stocks to Watch Amid Favorable Industry Trends

Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why

Zacks

a year ago

Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why

18 High Growth Low PE Stocks

Insider Monkey

a year ago

18 High Growth Low PE Stocks

Insider Sell: CymaBay Therapeutics Inc President of R&D Charles Mcwherter Sells 18,403 Shares

GuruFocus.com

a year ago

Insider Sell: CymaBay Therapeutics Inc President of R&D Charles Mcwherter Sells 18,403 Shares

Spotting Winners: Udemy (NASDAQ:UDMY) And Consumer Subscription Stocks In Q3

StockStory

a year ago

Spotting Winners: Udemy (NASDAQ:UDMY) And Consumer Subscription Stocks In Q3

Insider Sell: Apollo Commercial Real Estate Finance Inc President & CEO Stuart Rothstein ...

GuruFocus.com

a year ago

Insider Sell: Apollo Commercial Real Estate Finance Inc President & CEO Stuart Rothstein ...

Share on Social Networks: